Skip to content
OpenCapital
Get started

Progyny PGNY Sales & Marketing

Sales & Marketing at other companies

Privia Health Group, Inc. logo
Privia Health Group, Inc.PRVA
$8.13M+17.5%

Other financials

Income statement

See full
Revenue$328.5M+1.4%
Gross profit$83.1M+9.6%
Operating income$35.4M+46.4%
Net income$24.2M+60.9%
EPS (diluted)$0.29+70.6%

Balance sheet

See full
Cash & equivalents$131.6M+20.5%
Total debt$27.3M-5.6%
Total equity$439.3M-6.0%
Total assets$698.3M-4.4%

Cash flow

See full
Operating cash flow$45.9M-7.7%
CapEx$6.3M+123%
Free cash flow$39.6M-15.7%

Valuation

See full
Market cap$2.11B-27.1%

Profitability

See full
Gross margin24.1%+2.1pp
Operating margin7.5%+1.4pp
Net margin5.2%+0.9pp
FCF margin14.3%-1.9pp

Returns & leverage

See full
Return on equity14.9%+4.8pp
Debt / equity0.1×0.0×
Current ratio2.1×-0.3×

Where this comes from

Reported directly by Progyny in its filing.

Tagged under the XBRL concept us-gaap:SellingAndMarketingExpense.

The official record: Progyny’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Progyny's sales & marketing.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Progyny's sales & marketing?
Progyny (PGNY) reported sales & marketing of $16.88M in Q1 2026.
How has Progyny's sales & marketing changed year-over-year?
Progyny's sales & marketing decreased by 5.1% year-over-year, from $17.79M to $16.88M.
What is the long-term trend for Progyny's sales & marketing?
Over 4 years (2021 to 2025), Progyny's sales & marketing has grown at a 37.5% compound annual growth rate (CAGR), from $20.18M to $72.11M.
What does sales & marketing mean?
Costs of selling products and services including sales force compensation, commissions, marketing campaigns, trade shows, and customer acquisition expenses.